Cigna Group(CI) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 8:51 AM ET (Korea 9/11 21:51)
Full metrics table
| Index | S&P 500 | P/E | 11.62 | EPS (ttm) | 24.18 | Insider Own | 1.52% | Shs Outstand | 263.7M | Perf Week | -0.68% |
| Market Cap | 74.23B | Forward P/E | 8.39 | EPS next Y | 9.76% | Insider Trans | -5.32% | Shs Float | 260.2M | Perf Month | 2.57% |
| Enterprise Value | - | PEG | 1.11 | EPS next Q | 7.51 | Inst Own | 92.78% | Short Float | 2.01% | Perf Quarter | -5.04% |
| Income | 6.42B | P/S | 0.26 | EPS this Y | 2.23% | Inst Trans | -0.65% | Short Ratio | 3.15 | Perf Half Y | 7.68% |
| Sales | 282.50B | P/B | 1.74 | EPS next 5Y | 7.54% | ROA | 4.27% | Short Interest | 5.24M | Perf YTD | 2.06% |
| Book/sh | 161.62 | P/C | - | EPS past 3/5Y | 1.18% -0.69% | ROE | 15.49% | 52W High | -10.96% ($315.47) | Perf Year | -7.12% |
| Cash/sh | - | P/FCF | 8.15 | Sales past 3/5Y | 15.15% 11.35% | ROIC | 8.95% | 52W Low | 17.29% ($239.51) | Perf 3Y | -0.2% |
| Dividend Est. | $6.2 (2.21%) | EV/EBITDA | - | EPS Y/Y TTM | 31.47% | Gross Margin | - | Volatility(W/M) | 2.09% 1.91% | Perf 5Y | 37.24% |
| Dividend TTM | 6.19 | EV/Sales | - | Sales Y/Y TTM | 8.15% | Oper. Margin | 3.86% | ATR (14) | 6.67 | Perf 10Y | 118.69% |
| Dividend Ex-Date | 2026/9/8 | Quick Ratio | - | EPS Q/Q | 10.08% | Profit Margin | 2.27% | RSI (14) | 50.42 | Recom | 1.82 |
| Dividend Gr. 3/5Y | 10.47% 172.77% | Current Ratio | 0.85 | Sales Q/Q | 6.5% | SMA20 | 0.57% ($279.32) | Beta | 0.3 | Target Price | $341.17 |
| Payout | 27.23% | Debt/Eq | 0.75 | Earnings | 2026/7/30 | SMA50 | -0.88% ($283.4) | Rel Volume | 0.9 | Prev Close | $278.17 |
| Employees | 67700 | LT Debt/Eq | 0.68 | EPS/Sales Surpr. | 2.42% 2.17% | SMA200 | 0.44% ($279.68) | Avg Volume(3M) | 1.66M | Price | $280.91 |
| IPO | 1979/5/16 | Option/Short | Yes/Yes | Trades | 24783 | Volume | 1,505,519 | Change | 0.99% |
Company
CI is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
A leading global healthcare services company that integrates U.S. health insurance with pharmacy benefit management (including specialty pharmacy). Founded in 1792 with origins in the insurance business and headquartered in the United States, it has established itself as a key player in the U.S. health insurance and pharmacy benefit management market.
Over the past 1 year, roughly in the middle
11% below its 1-year high.
CI has weak earning power
Tap to view numbers
Growth is moderate
Earnings are expected to grow by +2.2% this year.
Tap to view numbers
The stock looks undervalued
Trading at 11.6 times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 2 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have paid off
Would have changed by -0.2% if bought 5 years ago.
Tap to view numbers
The dividend is on the small side
Pays 2.21% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 92.8%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
GQGU 0.04%
IHF 0.04%
DUSA 0.03%
MDPL 0.03%
VSMV 0.03%Special products that amplify (leveraged) or invert this single stock. They decay quickly and are not for long-term holding.
VCIT 69.0B
IAU 65.4B
XLF 54.2B
VTEB 46.0B
MUB 44.8BIt ranks #4 in the industry
Based on market cap of $74B.
CI $74B PER 11.6
UNH $349B PER 25.0
CVS $122B PER 25.2
ELV $90B PER 18.5
실적분석 · 7/30 Cigna Group ($CI) Q2 2026 Earnings Analysis — Adjusted EPS and Revenue Both Top Estimates, Full-Year Guidance Edged Up 투자 가이드 · 4/11 The Complete 2026 Guide to U.S. Dividend Aristocrats 투자 가이드 · 4/1 US Stock Taxes Complete Guide 2026 — Calculation Methods and Tax-Saving Strategies for Beginners See all posts on this stock FAQ
What kind of company is CI?
CI belongs to the Healthcare sector and operates in the Healthcare Plans industry.
What is the market cap of CI?
The market cap of CI is approximately $74.2B, ranking 232 within its sector.
Does CI pay dividends?
CI has a dividend yield of approximately 2.21%, with an annual dividend of $6.20.
What is the P/E ratio of CI?
CI has a P/E ratio of approximately 11.6x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for CI?
CI has recorded a 52-week high of $315.47 and a low of $239.51.
